Back to results
US 2006/0137031 A1Published application
Transgenic mice containing retinoid X receptor interacting protein gene disruptions
OwnerKeith Allen, Catherine Guenther +3inventors
InventorsKeith Allen, Catherine Guenther, Russell Phillips, Qin Zhang, Helene Baribault
Life of this patent
Estimating the term…
Abstract
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in the LXRB gene. Such transgenic mice are useful as models for disease, such as diabetes. The present invention is also directed to identifying agents that modulate LXRB gene function, and as potential treatments for various disease states and disease conditions, including diabetes.
Claims1
A targeting construct comprising:
- (a) a first polynucleotide sequence homologous to a LXRB gene;
- (b) a second polynucleotide sequence homologous to the LXRB gene;
- and
- (c) a selectable marker.
1 more element
Dependencies are inferred from the claim text.